Lead Product(s) : Lenzilumab
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Humanigen
Deal Size : Undisclosed
Deal Type : Agreement
Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab
Details : Aji Bio Pharma will provide drug product aseptic fill finish services for Humanigen. Lenzilumab, Humanigen’s Humaneered® anti-human granulocyte macrophage-colony stimulating factor monoclonal antibody is being administered as part of a Phase III study...
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
May 27, 2020
Lead Product(s) : Lenzilumab
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Humanigen
Deal Size : Undisclosed
Deal Type : Agreement